Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 21,653 results that match your search.21,653 results
  • On October 1 2000 two new Acts entered into force connected with industrial property rights. They concern biotechnological inventions and industrial designs. As both of them are important, the following is a brief summary of them.
  • Trade mark practitioners report record workloads, greater demands from clients and increased competition. James Nurton and Tabitha Parker investigate the latest trends in the second part of MIP’s fifth annual survey of the world’s leading IP firms
  • In Sime Darby Edible Products Ltd v Ngo Chew Hong Edible Oil Pte Ltd, a judgment was delivered by the High Court of Singapore on July 21 2000. The judgment sets out the approach taken by the local court in relation to the grounds on which a registered trade mark may be invalidated under Section 23 of the Trade Marks Act 1998 ("the Act" ).
  • ? CHINA: Proctor and Gamble has won its trade mark infringement case against Shanghai Chenxuan Zhineng Science and Technology Development Co for registering the name safeguard.com.cn which P&G registered in China in 1976.
  • Intellectual property management has, historically, been concerned with protection issues. In the first of three articles on IP value issues, Tony Samuel explains why value is the prime reason for IP protection
  • The dispute over parallel imports of cigarettes bearing the trade mark BELMONT (Bigott v Philip Morris) has been developing over several years, under the industrial property laws of the Andean Community.
  • ? JAPAN: Gene Logic and Amersham Pharmacia Biotech, the Japanese subsidiary of Amersham Pharmacia Biotech Ltd, announced an alliance granting Amersham distribution rights to market and sell Gene Logic's products to the Japanese market. Financial terms were not disclosed.
  • Counterfeit fear over new legislation
  • ? ARGENTINA: The American government has initiated legal action against Argentina over drug patents. The Americans believe the 1995 Argentine law does not provide adequate protection for the pharmaceutical industry , and does not fulfil TRIPs requirements.
  • New Decision improves protection